Expanding Treatment Options for Patients with Severe Renal Disease

Seoul St. Mary's Hospital announced on January 26 that it has successfully performed the nation's first transcatheter aortic valve implantation (TAVI) via the femoral vein.

Medical staff performing transcatheter aortic valve implantation (TAVI) via the right femoral vein and angiographic image of the patient's blood vessels. Seoul St. Mary's Hospital

Medical staff performing transcatheter aortic valve implantation (TAVI) via the right femoral vein and angiographic image of the patient's blood vessels. Seoul St. Mary's Hospital

View original image

This procedure was conducted as a live demonstration by the Korean Society of Interventional Cardiology. The patient was a 79-year-old woman with severely impaired kidney function due to diabetes. According to the hospital, she is recovering stably after the procedure.


Transfemoral vein TAVI is a new procedure designed for high-risk patients for whom access through the femoral artery or axillary artery is difficult. The procedure involves accessing the inferior vena cava through the femoral vein in the thigh, then entering the aorta to insert an artificial valve. Due to its high level of difficulty, it is performed only at a few highly experienced centers worldwide.


The patient who underwent the procedure had a history of myocardial infarction and heart failure, and a computed tomography (CT) scan revealed extensive calcification in the major arteries, making conventional TAVI access impossible. The medical team chose the transfemoral vein approach as an alternative.


Seoul St. Mary's Hospital stated that with the success of this procedure, it now has the capability to perform most of the currently available TAVI access methods. The hospital is now able to offer customized treatment strategies based on vascular condition and comorbidities.


Professor Jang Kiyook of the Department of Cardiology at Seoul St. Mary's Hospital, who performed the procedure, said, "Patients with severe aortic valve disease cannot recover without additional treatment due to persistent blood regurgitation or circulatory issues around the valve. I hope this becomes the first treatment to offer hope to patients who had no interventional treatment alternatives and were forced to choose surgery despite the physical burden."



The Cardiovascular and Cerebrovascular Center at Seoul St. Mary's Hospital is a major domestic center that has performed more than 1,000 cumulative TAVI procedures. It has also been designated as a TAVI education center of excellence (CoE) by Medtronic and MicroPort.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing